48,830
edits
(→Myelolipoma: more) |
|||
Line 403: | Line 403: | ||
*Mitoses/karyorrhectic cells. | *Mitoses/karyorrhectic cells. | ||
*Molecular abnormalities. | *Molecular abnormalities. | ||
===IHC=== | |||
*PGP 9.5 +ve.<ref>{{Cite journal | last1 = Ootsuka | first1 = S. | last2 = Asami | first2 = S. | last3 = Sasaki | first3 = T. | last4 = Yoshida | first4 = Y. | last5 = Nemoto | first5 = N. | last6 = Shichino | first6 = H. | last7 = Chin | first7 = M. | last8 = Mugishima | first8 = H. | last9 = Suzuki | first9 = T. | title = Useful markers for detecting minimal residual disease in cases of neuroblastoma. | journal = Biol Pharm Bull | volume = 31 | issue = 6 | pages = 1071-4 | month = Jun | year = 2008 | doi = | PMID = 18520032 }}</ref> | |||
**PGP = protein gene product. | |||
=See also= | =See also= |
edits